AMGN reports positive phase-3 data for Humira FoB in RA: http://finance.yahoo.com/news/amgen-announces-positive-top-line-210100426.html Note: AMGN is partnered with ACT on FoBs for oncology (#msg-70097496), but not on the Humira FoB.